Transcat, Inc. (NASDAQ:TRNS) Stake Lessened by Victory Capital Management Inc.

Key Points

• Victory Capital Management Inc. reduced its stake in Transcat, Inc. by 20.7%, owning 27,537 shares worth approximately $2.05 million after selling 7,173 shares in the first quarter.
• Aquatic Capital increased its holdings in Transcat by an impressive 1,052% during the fourth quarter, while GAMMA Investing grew its stake by 10,137.5% in Q1.
• Analysts have mixed opinions on Transcat, with a consensus rating of "Moderate Buy" and an average target price of $112.20, while the company's recent earnings report showed a slight miss on EPS.

Victory Capital Management Inc. reduced its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 20.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 27,537 shares of the scientific and technical instruments company's stock after selling 7,173 shares during the period. Victory Capital Management Inc. owned about 0.30% of Transcat worth $2,050,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC increased its position in shares of Transcat by 1,052.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock valued at $122,000 after purchasing an additional 1,052 shares during the last quarter. GAMMA Investing LLC boosted its stake in Transcat by 10,137.5% during the 1st quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,622 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in shares of Transcat in the 4th quarter worth $190,000. ProShare Advisors LLC lifted its stake in shares of Transcat by 49.1% in the 4th quarter. ProShare Advisors LLC now owns 2,542 shares of the scientific and technical instruments company's stock worth $269,000 after acquiring an additional 837 shares during the period. Finally, Centiva Capital LP lifted its stake in shares of Transcat by 6.0% in the 4th quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company's stock worth $318,000 after acquiring an additional 171 shares during the period. 98.34% of the stock is owned by hedge funds and other institutional investors.

Transcat Trading Down 2.6%

TRNS stock traded down $2.00 during midday trading on Friday, reaching $74.43. 17,584 shares of the company's stock traded hands, compared to its average volume of 106,210. The business has a 50-day moving average price of $83.47 and a two-hundred day moving average price of $81.98. Transcat, Inc. has a fifty-two week low of $67.56 and a fifty-two week high of $133.72. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.29 and a quick ratio of 1.87. The company has a market capitalization of $693.65 million, a P/E ratio of 47.76 and a beta of 0.73.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). Transcat had a return on equity of 6.47% and a net margin of 5.21%. The firm had revenue of $77.13 million for the quarter, compared to analyst estimates of $76.40 million. Transcat's quarterly revenue was up 8.8% compared to the same quarter last year. Equities research analysts forecast that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on TRNS shares. HC Wainwright reiterated a "buy" rating and issued a $116.00 price target on shares of Transcat in a report on Wednesday, June 25th. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a report on Wednesday, May 28th. Finally, Lake Street Capital started coverage on shares of Transcat in a report on Thursday, July 10th. They set a "buy" rating and a $105.00 price target for the company. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Transcat currently has an average rating of "Moderate Buy" and a consensus price target of $112.20.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.